Roth Capital Starts Catalyst Pharmaceutical Partners (CPRX) at Buy
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Roth Capital initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) with a Buy. PT $4.
For more ratings news on Catalyst Pharmaceutical Partners click here and for the rating history of Catalyst Pharmaceutical Partners click here.
Shares of Catalyst Pharmaceutical Partners closed at $1.78 yesterday.
For more ratings news on Catalyst Pharmaceutical Partners click here and for the rating history of Catalyst Pharmaceutical Partners click here.
Shares of Catalyst Pharmaceutical Partners closed at $1.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
